iShares Biotechnology ETF (IBB) To Go Ex-Dividend on March 18th

iShares Biotechnology ETF (NASDAQ:IBB) declared a dividend on Monday, March 17th, NASDAQ Dividends reports. Investors of record on Tuesday, March 18th will be given a dividend of 0.1212 per share by the financial services provider on Friday, March 21st. The ex-dividend date of this dividend is Tuesday, March 18th. This is a 94.3% increase from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $134.09 on Wednesday. The company has a 50 day moving average price of $136.26 and a 200 day moving average price of $139.57. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The firm has a market capitalization of $6.11 billion, a price-to-earnings ratio of 27.83 and a beta of 0.77.

Institutional Investors Weigh In On iShares Biotechnology ETF

A hedge fund recently bought a new stake in iShares Biotechnology ETF stock. Brighton Jones LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 1,517 shares of the financial services provider’s stock, valued at approximately $201,000. 62.45% of the stock is currently owned by institutional investors.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.